BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 22741475)

  • 21. [Necessity of applying pharmacovigilance in post-marketing safety monitoring of traditional Chinese medicine injections].
    Wang HN; Chen W; Fu Z; Du WM; He J
    Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):612-4. PubMed ID: 18536393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of the importance of herbs in the Chinese herbal compounds based on the theory of rough sets].
    Liu M
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Oct; 30(5):1007-9. PubMed ID: 24459961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chinese medicine adverse reactions' literature statistical analysis in recent five years].
    Xiang F; Zhang X
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(19):2755-8. PubMed ID: 22242443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicological risks of Chinese herbs.
    Shaw D
    Planta Med; 2010 Dec; 76(17):2012-8. PubMed ID: 21077025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Influencing factor and mechanism analysis of adverse drug reaction in traditional Chinese medicine injection].
    Wei X; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2748-51. PubMed ID: 23285926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Explore pros and cons of proproetary Chinese medicines and Western medicines].
    Jin YQ; Jiang ZY
    Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2407-9. PubMed ID: 19157140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality and safety of Chinese herbal medicines guided by a systems biology perspective.
    Wang J; van der Heijden R; Spruit S; Hankermeier T; Chan K; van der Greef J; Xu G; Wang M
    J Ethnopharmacol; 2009 Oct; 126(1):31-41. PubMed ID: 19683045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Debate personification of property of peaceful property of drug in cooperation of prescription of traditional Chinese medicine].
    Sun B; Deng J
    Zhongguo Zhong Yao Za Zhi; 2009 Jun; 34(12):1615-6. PubMed ID: 19777855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Thought on several problems of post-marketing herbs clinical evaluation in special populations].
    Zhou A; Lian F
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2776-8. PubMed ID: 22292362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Decision rules model for studying the law of compatibility of categorized formula based on rough set].
    Wang X; Zhang L; Luo L; Li J; Wang J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Feb; 29(1):121-4. PubMed ID: 22404021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Research actuality and expectation on embryo toxicity of traditional Chinese medicine].
    Lin N; Hu JP
    Zhongguo Zhong Yao Za Zhi; 2005 Sep; 30(17):1317-20. PubMed ID: 16323537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A computer method for validating traditional Chinese medicine herbal prescriptions.
    Wang JF; Cai CZ; Kong CY; Cao ZW; Chen YZ
    Am J Chin Med; 2005; 33(2):281-97. PubMed ID: 15974487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Thinking about evaluation of proprietary Chinese medicines containing toxic herbs during switch process of non-prescription drugs].
    Xia D; Cheng G; Li X; Zhou J; Xiao A; Zhang C; Du X
    Zhongguo Zhong Yao Za Zhi; 2010 Dec; 35(24):3389-92. PubMed ID: 21438414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Application and progress of data mining in study of compatibility law of traditional Chinese medicine].
    Liu ML; Zhang XY; Ding L; Pan SM; Wu DY; Li XY
    Zhongguo Zhong Yao Za Zhi; 2021 Oct; 46(20):5233-5239. PubMed ID: 34738424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study of combination methods for formula composition of Chinese herbal medicines and their components].
    Liu XJ; Su SB
    Zhong Xi Yi Jie He Xue Bao; 2009 Jul; 7(7):601-6. PubMed ID: 19615311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compatibility art of traditional Chinese medicine: from the perspective of herb pairs.
    Wang S; Hu Y; Tan W; Wu X; Chen R; Cao J; Chen M; Wang Y
    J Ethnopharmacol; 2012 Sep; 143(2):412-23. PubMed ID: 22871585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current situation of toxicity classification of Chinese materia medica and its research thoughts].
    Sun W; Hou X; Wang B; Zhu Y; Zhang S; Chang H; Sun J
    Zhongguo Zhong Yao Za Zhi; 2012 Aug; 37(15):2199-201. PubMed ID: 23189717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Compatibility for toxicity attenuation of toxic traditional Chinese medicine: a review and strategies].
    Gao Y; Li C; Liang AH; Gao XM; Zhao YL
    Zhongguo Zhong Yao Za Zhi; 2022 Apr; 47(8):1989-1994. PubMed ID: 35531713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study on incompatibility of traditional Chinese medicines].
    Fan XS; Duan JA; Hua HM; Qian DW; Shang EX; Guo JM
    Zhongguo Zhong Yao Za Zhi; 2015 Apr; 40(8):1630-4. PubMed ID: 26281612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Research progress of Chinese herbal medicine and traditional Chinese medicine resulting in liver injury].
    Wang J; Zhou C
    Zhongguo Zhong Yao Za Zhi; 2011 Dec; 36(23):3371-4. PubMed ID: 22393753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.